1. Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma. (1st January 2021) Authors: Zhang, Lina; Shen, Xuxing; Yu, Wenjun; Li, Jing; Zhang, Jue; Zhang, Run; Li, Jianyong; Chen, Lijuan Journal: Annals of medicine Issue: Volume 53:Number 1(2021) Page Start: 1547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LncRNA MEG3 promotes the sensitivity of bortezomib by inhibiting autophagy in multiple myeloma. (December 2022) Authors: Zang, Xiaoyan; Wang, Jing; Xia, Yuan; Li, Jianyong; Chen, Lijuan; Gu, Yan; Shen, Xuxing Journal: Leukemia research Issue: Volume 123(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Survival trends and prognostic factors in patients with solitary plasmacytoma of bone: A population‐based study. (3rd November 2020) Authors: Shen, Xuxing; Liu, Shu; Wu, Chao; Wang, Jing; Li, Jianyong; Chen, Lijuan Journal: Cancer medicine Issue: Volume 10:Number 2(2021) Page Start: 462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗